Advertisement

Neurocritical Care

, 15:241 | Cite as

Rebleeding After Aneurysmal Subarachnoid Hemorrhage

  • R. M. Starke
  • E. S. ConnollyJr.
  • The Participants in the International Multi-disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage
Review

Abstract

Rebleeding after initial aneurysmal subarachnoid hemorrhage (SAH) can have substantial impact on overall patient outcome. While older studies have suggested rebleeding occurs in about 4% of patients during the first day after initial aneurysmal bleed, these studies may have failed to capture very early rebleeds and, consequently, underestimated the impact of rebleeding. An electronic literature search was performed to identify English-language articles published or available for review from February 1975 through October 2010. A total of 43 articles (40 original research and 3 review articles) focused on rebleeding after initial aneurysmal SAH in humans were selected for review. Although most studies supported an incidence of rebleeding ≤4%, studies investigating ultra-early rebleeding reported bleeding within the first 24 h following aneurysmal SAH in as many as 9–17% of patients, with most cases occurring within 6 h of initial hemorrhage. Overall, studies investigating antifibrinolytic therapy to reduce rebleeding have failed to clearly demonstrate overall therapeutic benefit. Short-course antifibrinolytic therapy may have a role prior to initial aneurysm repair, although insufficient data are currently available.

Keywords

Antifibrinolytic Predictor Ultra-early rebleeding 

References

  1. 1.
    Ameen AA, Illingworth R. Anti-fibrinolytic treatment in the pre-operative management of subarachnoid haemorrhage caused by ruptured intracranial aneurysm. J Neurol Neurosurg Psychiatry. 1981;44:220–6.PubMedCrossRefGoogle Scholar
  2. 2.
    Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Koike T, Tanaka R. Ultra-early rebleeding in spontaneous subarachnoid hemorrhage. J Neurosurg. 1996;84:35–42.PubMedCrossRefGoogle Scholar
  3. 3.
    Hillman J, Fridriksson S, Nilsson O, Yu Z, Saveland H, Jakobsson KE. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J Neurosurg. 2002;97:771–8.PubMedCrossRefGoogle Scholar
  4. 4.
    Laidlaw JD, Siu KH. Ultra-early surgery for aneurysmal subarachnoid hemorrhage: outcomes for a consecutive series of 391 patients not selected by grade or age. J Neurosurg. 2002;97:250–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Larsen CC, Eskesen V, Hauerberg J, Olesen C, Romner B, Astrup J. Considerable delay in diagnosis and acute management of subarachnoid haemorrhage. Dan Med Bull. 2010;57:A4139.PubMedGoogle Scholar
  6. 6.
    Harrigan MR, Rajneesh KF, Ardelt AA, Fisher WS 3rd. Short-term antifibrinolytic therapy before early aneurysm treatment in subarachnoid hemorrhage: effects on rehemorrhage, cerebral ischemia, and hydrocephalus. Neurosurgery. 2010;67:935–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Jane JA, Winn HR, Richardson AE. The natural history of intracranial aneurysms: rebleeding rates during the acute and long term period and implication for surgical management. Clin Neurosurg 1977;24:176–84.PubMedGoogle Scholar
  8. 8.
    Kassell NF, Torner JC. Aneurysmal rebleeding: a preliminary report from the Cooperative Aneurysm Study. Neurosurgery. 1983;13:479–81.PubMedCrossRefGoogle Scholar
  9. 9.
    Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL. The international cooperative study on the timing of aneurysm surgery. Part 1. Overall management results. J Neurosurg. 1990;73:18–36.PubMedCrossRefGoogle Scholar
  10. 10.
    Kassell NF, Torner JC, Jane JA, Haley EC Jr, Adams HP. The international cooperative study on the timing of aneurysm surgery. Part 2. Surgical results. J Neurosurg. 1990;73:37–47.PubMedCrossRefGoogle Scholar
  11. 11.
    Leipzig TJ, Redelman K, Horner TG. Reducing the risk of rebleeding before early aneurysm surgery: a possible role for antifibrinolytic therapy. J Neurosurg. 1997;86:220–5.PubMedCrossRefGoogle Scholar
  12. 12.
    Molyneux A, Kerr R, Stratton I, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet. 2002;360:1267–74.PubMedCrossRefGoogle Scholar
  13. 13.
    Molyneux AJ, Kerr RS, Birks J, et al. Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): long-term follow-up. Lancet Neurol. 2009;8:427–33.PubMedCrossRefGoogle Scholar
  14. 14.
    Molyneux AJ, Kerr RS, Yu LM, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet. 2005;366:809–17.PubMedCrossRefGoogle Scholar
  15. 15.
    Plowman RS, Clarke A, Clarke M, Byrne JV. Sixteen-year single-surgeon experience with coil embolization for ruptured intracranial aneurysms: recurrence rates and incidence of late rebleeding. J Neurosurg. 2011;114:863–74.PubMedCrossRefGoogle Scholar
  16. 16.
    Starke RM, Kim GH, Fernandez A, et al. Impact of a policy of early antifibrinolytic therapy for the prevention of acute rebleeding after aneurysmal subarachnoid hemorrhage. Stroke. 2008;39:2617–21.PubMedCrossRefGoogle Scholar
  17. 17.
    Cha KC, Kim JH, Kang HI, Moon BG, Lee SJ, Kim JS. Aneurysmal rebleeding: factors associated with clinical outcome in the rebleeding patients. J Korean Neurosurg Soc. 2010;47:119–23.PubMedCrossRefGoogle Scholar
  18. 18.
    Tong Y, Gu J, Fan WJ, Yu JB, Pan JW, Wan S, Zhou YQ, Zheng XJ, Zhan RY. Patients with supratentorial aneurysmal subarachnoid hemorrhage during the intermediate period: waiting or actively treating. Int J Neurosci. 2009;119:1494–506.PubMedCrossRefGoogle Scholar
  19. 19.
    Ruigrok YM, Slooter AJ, Rinkel GJ, Wijmenga C, Rosendaal FR. Genes influencing coagulation and the risk of aneurysmal subarachnoid hemorrhage, and subsequent complications of secondary cerebral ischemia and rebleeding. Acta Neurochir (Wien). 2010;152:257–62.CrossRefGoogle Scholar
  20. 20.
    Tanno Y, Homma M, Oinuma M, Kodama N, Ymamoto T. Rebleeding from ruptured intracranial aneurysms in North Eastern Province of Japan. A cooperative study. J Neurol Sci. 2007;258:11–6.PubMedCrossRefGoogle Scholar
  21. 21.
    Heelingman CA, van den Bergh WM, Beijer IS, et al. Risk of rebleeding after treatment of acute hydrocephalus in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2007;38:96–9.CrossRefGoogle Scholar
  22. 22.
    Machiel Pleizier C, Algra A, Velthuis BK, Rinkel GJ. Relation between size of aneurysms and risk of rebleeding in patients with subarachnoid haemorrhage. Acta Neurochir. 2006;148:1277–9.CrossRefGoogle Scholar
  23. 23.
    Beck J, Raabe A, Szelenyi A, et al. Sentinel headache and the risk of rebleeding after aneurysmal subarachnoid hemorrhage. Stroke. 2006;37:2733–7.PubMedCrossRefGoogle Scholar
  24. 24.
    Kitsua Y, Suzuki N, Sugiyama M, Yamamoto I. Changes in level of consciousness and association with hyperglycemia as tool for predicting and preventing re-bleeding after spontaneous subarachnoid hemorrhage. Prehosp Disaster Med. 2006;21:190–5.Google Scholar
  25. 25.
    Ruijs AC, Dirven CM, Algra A, Beijer I, Vandertop WP, Rinkel G. The risk of rebleeding after external lumbar drainage in patients with untreated ruptured cerebral aneurysms. Acta Neurochir. 2005;147:1157–61.CrossRefGoogle Scholar
  26. 26.
    Kusumi M, Yamada M, Kitahara T, et al. Rerupture of cerebral aneurysms during angiography—a retrospective study of 13 patients with subarachnoid hemorrhage. Acta Neurochir. 2005;147:831–7.CrossRefGoogle Scholar
  27. 27.
    Naidech AM, Ianjua N, Kreiter KT, et al. Predictors and impact of aneurysm rebleeding after subarachnoid hemorrhage. Arch Neurol. 2005;62:410–6.PubMedCrossRefGoogle Scholar
  28. 28.
    McIver JI, Friedman JA, Wijdicks EF, et al. Preoperative ventriculostomy and rebleeding after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2002;97:1042–4.PubMedCrossRefGoogle Scholar
  29. 29.
    Edner G, Ronne-Engström E. Can early admission reduce aneurysmal rebleeds? A prospective study on aneurysmal incidence, aneurysmal rebleeds, admission and treatment delays in a defined region. Br J Neurosurg. 1991;5:601–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Steiger HJ, Fritschi J, Seiler RW. Current pattern of in-hospital aneurysmal rebleeds. Analysis of a series treated with individually timed surgery and intravenous nimodipine. Acta Neurochir. 1994;127:21–6.CrossRefGoogle Scholar
  31. 31.
    Roos YM, Beenen LM, Goren RM, Albrecht KW, Vermeulen M. Timing of surgery in patients with aneurysmal subarachnoid haemorrhage: rebleeding is still the major cause of poor outcome in neurosurgical units that aim at early surgery. J Neurol Neurosurg Psychiatry. 1997;63:490–3.PubMedCrossRefGoogle Scholar
  32. 32.
    Hillman J, von Essen C, Leszniewski W, Johansson I. Significance of “ultra-early” rebleeding in subarachnoid hemorrhage. J Neurosurg. 1988;68:901–7.PubMedCrossRefGoogle Scholar
  33. 33.
    Larsen CC, Eskesen V, Hauerberg J, Olesen C, Romner B, Astrup J. Considerable delay in diagnosis and acute management of subarachnoid haemorrhage. Ugeskr Laeger. 2010;172:1442.PubMedGoogle Scholar
  34. 34.
    Girvin JP. The use of antifibrinolytic agents in the preoperative treatment of ruptured intracranial aneurysms. Trans Am Neurol Assoc. 1973;98:150–2.PubMedGoogle Scholar
  35. 35.
    van Rossum J, Wintzen AR, Endtz LJ, Schoen JH, de Jonge H. Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial. Ann Neurol. 1977;2:238–42.PubMedCrossRefGoogle Scholar
  36. 36.
    Chandra B. Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial. Ann Neurol. 1978;3:502–4.PubMedCrossRefGoogle Scholar
  37. 37.
    Maurice-Williams RS. Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms? Br Med J. 1978;1:945–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Kaste M, Ramsay M. Tranexamic acid in subarachnoid hemorrhage. A double-blind study. Stroke. 1979;10:519–22.PubMedCrossRefGoogle Scholar
  39. 39.
    Fodstad H, Forssell A, Liliequist B, Schannong M. Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial. Neurosurgery. 1981;8:158–65.PubMedCrossRefGoogle Scholar
  40. 40.
    Vermeulen M, Lindsay KW, Murray GD, et al. Antifibrinolytic treatment in subarachnoid hemorrhage. N Engl J Med. 1984;311:432–7.PubMedCrossRefGoogle Scholar
  41. 41.
    Tsementzis SA, Hitchcock ER, Meyer CH. Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study. Acta Neurochir. 1990;102:1–10.CrossRefGoogle Scholar
  42. 42.
    Roos Y. Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. Star study group. Neurology. 2000;54:77–82.PubMedGoogle Scholar
  43. 43.
    Jane JA, Kassell NF, Torner JC, Winn HR. The natural history of aneurysms and arteriovenous malformations. J Neurosurg. 1985;62:321–3.PubMedCrossRefGoogle Scholar
  44. 44.
    Kassell NF, Drake CG. Timing of aneurysm surgery. Neurosurgery. 1982;10:514–9.PubMedCrossRefGoogle Scholar
  45. 45.
    Roos, Y.B., Rinkel, G., Vermeulen, M., Algra, A., van Gijn, J.: Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2003;CD001245.Google Scholar
  46. 46.
    Lylyk P, Miranda C, Ceratto R, et al. Curative endovascular reconstruction of cerebral aneurysms with the pipeline embolization device: the Buenos Aires experience. Neurosurgery. 2009;64:632–42.PubMedCrossRefGoogle Scholar
  47. 47.
    Nelson PK, Lylyk P, Szikora I, Wetzel SG, Wanke I, Fiorella D. The pipeline embolization device for the intracranial treatment of aneurysms trial. Am J Neuroradiol. 2011;32:34–40.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • R. M. Starke
    • 1
  • E. S. ConnollyJr.
    • 2
  • The Participants in the International Multi-disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage
  1. 1.Department of NeurosurgeryUniversity of Virginia School of MedicineCharlottesvilleUSA
  2. 2.Department of NeurosurgeryColumbia University College of Physicians and SurgeonsNew YorkUSA

Personalised recommendations